BC
Bhagyashri Chandrashekhar Sabe
About Bhagyashri Chandrashekhar Sabe
Data last updated:
Bhagyashri Chandrashekhar Sabe is a Director at Metamed Pharma Private Limited (since 2022). The company operates in Trading. Metamed Pharma Private Limited reported revenue of ₹75,400 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Metamed Pharma Private Limited U51909MH2022PTC389791 | Director | 02 Sep 2022 | 2022 | ₹75,400 (FY 2023) | Active |
Board colleagues of Bhagyashri Chandrashekhar Sabe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kunal Deelip Sapkale | 07586114 | Metamed Pharma Private Limited | Director |
| Lalit Dagadu Sonawane | 09724877 | Metamed Pharma Private Limited | Director |
| Rupali Ketan Pachorkar | 10118967 | Metamed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhagyashri Chandrashekhar Sabe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhagyashri Chandrashekhar Sabe
Bhagyashri Chandrashekhar Sabe currently holds 1 directorship: Metamed Pharma Private Limited (Director, since 02 Sep 2022, revenue ₹75,400 (FY 2023)).
Bhagyashri Chandrashekhar Sabe was first appointed on 02 Sep 2022 as Director at Metamed Pharma Private Limited.
The current boards of Bhagyashri Chandrashekhar Sabe's companies include Kunal Deelip Sapkale (Metamed Pharma Private Limited), Lalit Dagadu Sonawane (Metamed Pharma Private Limited), Rupali Ketan Pachorkar (Metamed Pharma Private Limited).